NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity, Fitness & Wellness Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity, Fitness & Wellness Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Biochemistry



Researchers achieve first signal on the Cryogenic Maldi-FTMS



July 14th, 2007

Researchers at Boston University School of Medicine (BUSM) recently achieved first signal on the Cryogenic Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Mass Spectrometry (MALDI-FTMS) being developed at the school’s Cardiovascular Proteomics Center (CPC). The Fourier transform mass spectrometer is the highest performance instrumentation currently available to those interested in structural characterization of proteins and other biomolecules.

“When working to its full capacity, the Cryogenic MALDI-FTMS will greatly enhance how we study and understand disease,” says Peter B. O’Connor, PhD, research associate professor in the Department of Biochemistry at...


Source: Obesity, Fitness & Wellness Week (2007-07-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login